---
annotations:
- type: Disease Ontology
  value: pulmonary fibrosis
- type: Pathway Ontology
  value: angiotensin II signaling pathway via AT1 receptor
- type: Disease Ontology
  value: COVID-19
- type: Cell Type Ontology
  value: fibroblast
authors:
- Marvin M2
- Finterly
description: AOP based on https://aopwiki.org/aops/319
last-edited: 2021-05-28
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP5035
- /instance/WP5035
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP5035.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: AOP based on https://aopwiki.org/aops/319
  keywords:
  - Bradykinin system, hyperactivated
  - Bradykinin signaling network
  - Collagen biosynthesis and modifying enzymes
  - Prostaglandin signaling
  - Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)
  - 'KE1743: Increased plasma Angiotensin II'
  - Overview of proinflammatory and profibrotic mediators
  - NF-KB pathway
  - 'KE1276: Lung Fibrosis'
  - Increase activation, Nuclear factor kappa B (NF-kB)
  - 'KE68: Collagen Accumulation'
  - 'KE1752: Increased Angiotensin II'
  - Bradykinin receptor B1 activation
  - Increased, Reactive oxygen species
  - Renin Angiotensin Aldosterone System
  - Kinin-Kallikrein Pathway
  - Oxidative stress
  - Increased, Prostaglandin E2 secretion
  - Angiotensin II receptor type 1 pathway
  - Increased, secretion of proinflammatory and profibrotic mediators
  - ACE2 inhibition
  - Metabolism of Angiotensinogen to Angiotensins
  - 'KE1740: ACE2 inhibition'
  license: CC0
  name: ACE2 inhibition leads to pulmonary fibrosis
seo: CreativeWork
title: ACE2 inhibition leads to pulmonary fibrosis
wpid: WP5035
---